See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · InformexUSA 2012 · New Orleans, Louisiana · February 14-17, 2012 · Booth 2514

Research Area · Hypertension

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
10007975 (±)11,12-DHET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-17 9.767403314917 -11-12-dhet-d11 (±)11,12-DiHETrE-d11 epoxides epoxygenases DHT hydrolases (+/-)11,12-DiHETrEs deuterated epoxide hydrolase deuterated deuterium 9.767403314917
10006413 (±)11(12)-EET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-25 25.703609576427 -11-12-eet-d11 (±)11(12)-EpETrE-d11 epoxides epoxygenases 11,12-EETs cytochrome P450 (+/-)11,12-EpETrEs (+/-)11(12)-EpETrEs deuterated deuterium 25.703609576427
10004549 11β-Hydroxysteroid Dehydrogenase (Type 2) Polyclonal Antibody - 2005-10-05 6.599152854512 11-hydroxysteroid-dehydrogenase-type-2-polyclonal-antibody Corticosteroid 11β-Dehydrogenase Isozyme 2; 11β-HSD2 proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry corticosteroids regulations sodium homeostasis pathophysiology hypertension converts converting cortisol inactive cortisone mutations genes encoding induction hypertension hypokalemia syndromes mineralcorticoid excess mRNA expressed placenta target tissues kidneys mouse murine tissue-specific developmentally regulated glucocorticoid-medicated maturation 11b-HSD 11beta-HSD 11.beta.-HSD 11b HSD 11b-hydroxysteroid 11beta-hydroxysteroid endocrinology immunoblotting 6.599152854512
10008040 (±)14,15-DHET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-18 20.872209944752 -14-15-dhet-d11 (±)14,15-DiHETrE-d11 epoxides epoxygenases DHT hydrolases (+/-)14,15-DiHETrEs deuterated epoxide hydrolase deuterium 20.872209944752
10004946 14,15-EE-5(Z)-E Exclusive 519038-92-7 ≥98% ✓ 2007-01-15 34.172044198895 14-15-ee-5-z-e 14,15-Epoxyeicosa-5(Z)-enoic Acid 14,15-EpETrE 14,15-EETs antagonists hypertension vasodilation vasodilator vasoconstriction vasoconstrictor EDHT endothelium-derived hyperpolarizing factor U46619 bovine arteries endocrinology EEZE 34.172044198895
10010486 14,15-EE-8(Z)-E Exclusive 519038-93-8 ≥98% ✓ 2008-11-03 13.297796193983 14-15-ee-8-z-e 14,15-Epoxyeicosa-8(Z)-enoic Acid 14,15-EETs 14,15-EpETrEs vasodilation vascular disease hypertension EEZE 13.297796193983
10009286 (±)14(15)-EET-SI 218461-97-3 ≥95% 2007-05-14 15.116151012891 -14-15-eet-si (±)14(15)-EET-sulfonimide; (±)14(15)-EpETrE-SI arachidonic acid AA endothelium epoxytrienoic acid EETs EpETrEs cytochromes P450 acetylcholine bradykinin sulfonamide analog tyrosine phosphorylation mitogenesis renal epithelial cells hypertension EDHF 15.116151012891
10010635 (±)16-HETE 128914-46-5 ≥98% 2008-06-09 24.688839779005 -16-hete CYP450 eicosanoid metabolism kidneys ATPase ion transport vasodilation renal hypertension 24.688839779005
10004385 16(R)-HETE 183509-22-0 ≥98% 2008-07-28 2.140883977900 16-r-hete CYP450 eicosanoid metabolism kidney ion transport vasodilation renal hypertension HETEs 2.140883977900
13076 16(R)-Iloprost - ≥98% 2008-10-10 20.081736385161 16-r-iloprost prostacyclin platelet aggregation IP receptors EP vasodilation pulmonary hypertension stereoisomers inhibits inhibitors inhibition iloprosts PGI2 20.081736385161
10004384 16(S)-HETE 183509-23-1 ≥98% 2008-07-23 1.933977900552 16-s-hete inhibitors inhibits inhibitions CYP450 eicosanoid metabolism kidneys ATPase ion transport renal hypertension HETEs 16SHETE 16S-HETE 16 S HETE 1.933977900552
13077 16(S)-Iloprost 74843-14-4 ≥98% 2008-10-10 20.081736385161 16-s-iloprost prostacyclin platelet aggregation IP receptors EP vasodilation pulmonary hypertension stereoisomers iloprosts inhibits inhibitors inhibition PGI2 20.081736385161
10011305 17(S)-HETE 183509-25-3 ≥98% 2008-08-25 12.577142857143 17-s-hete CYP450 Eicosanoid metabolism kidney ATPase ion transport renal hypertension 12.577142857143
10010638 (±)18-HETE 133268-58-3 ≥97% 2008-06-13 6.341436464088 -18-hete CYP450 eicosanoid metabolism kidney vasodilation CYP2E1 20-HETE 20HETE 18HETE renal hypertension 6.341436464088
10007767 19(R)-HETE 115461-39-7 ≥98% 2008-05-27 7.770165745856 19-r-hete hypertension arterioles CYP450 kidneys angiotensin II vasodilator vasoconstricition 20-HETE 19HETE 19-HETE renal 19 HETE 7.770165745856
10007766 19(S)-HETE Exclusive 115461-40-0 ≥98% ✓ 2010-04-06 27.706500920810 19-s-hete cytochromes P450 CYP450 metabolites arachidonic acids kidneys angiotensin II CYP2E1 vasodilators renal preglomerular vessels ATPase hypertension arterioles vasoconstriction Acids Hydroxyeicosatetraenoic Hydroxyeicosatetraenoic Acids HETE 27.706500920810
10007912 20-carboxy Arachidonic Acid Exclusive 79551-84-1 >98% ✓ 2007-08-15 38.503038674033 20-carboxy-arachidonic-acid 20-COOH-AA 20-HETE metabolites PPAR.alpha. PPAR.gamma. vasorelaxation activators CYP4F3B hypertension cytochrome P450 CYP450 perioxisome proliferator activated receptor PPARs PPARalpha PPARgamma 38.503038674033
10008596 (±)5(6)-EET Ethanolamide - ≥95% 2006-10-20 8.898524072612 -5-6-eet-ethanolamide (±)5(6)-EpETrE Ethanolamide epoxides epoxygenases 5,6-EETs cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs fatty acids esters ethanolamides metabolites AEA anandamides arachidonoyl neurotransmitters cannabinergic endocannabinoids CB1 CB2 receptors central peripheral FAAH hydrolases metabolism lipoxygenases inhibition (±)5(6)-Epoxy eicosatrienoyl 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide cannabinoids cbs synthetic 8.898524072612
13260 6-keto Prostaglandin E1 67786-53-2 >99% 75.689309392265 6-keto-prostaglandin-e1 6-keto PGE1 6-keto-PGE1 metabolites prostaglandins 75.689309392265
10007210 6-keto Prostaglandin E1 Lipid Maps MS Standard 67786-53-2 >99% 2008-11-03 50.241491712707 6-keto-prostaglandin-e1-lipid-maps-ms-standard 6-keto PGE1 6-keto-PGE1 metabolites prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS 50.241491712707
10009998 (±)8,9-DHET-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2008-03-17 9.669005524862 -8-9-dhet-d11 (±)8,9-DiHETrE-d11 epoxides epoxygenases DHT hydrolases (+/-)14,15-DiHETrEs deuterated epoxide hydrolase deuterated deuterium 9.669005524862
18112 8,9-EE-14(Z)-E Exclusive - ≥95% ✓ 2009-03-15 9.932679558011 8-9-ee-14-z-e 8,9-Epoxyeicosa-14(Z)-enoic Acid 14,15-EETs 14,15-EpETrEs vasodilation vascular disease hypertension EEZE 9.932679558011
10009532 (±)8(9)-EET-d11 - ≥99% deuterated forms (d1-d11) 2008-03-25 12.430920810313 -8-9-eet-d11 (±)8(9)-EpETrE-d11 epoxides epoxygenases cytochrome P450 (±)8,9-EpETrEs (+/-)8,9-EpETrEs fatty acids (+/-)8(9)EpETrEs 8(9)EETs eicosatrienoic 8,9-EETs deuterated racemic mixture 12.430920810313
10008597 (±)8(9)-EET Ethanolamide - ≥98% 2007-07-05 15.558743093922 -8-9-eet-ethanolamide (±)8(9)-EpETrE Ethanolamide AEA endocannabinoids arachidonoyl ethanolamide CYP450 cytochrome P450 metabolism ethanolamides hypertension cannabinoids cbs synthetic 15.558743093922
589320 8-hydroxy-2-deoxy Guanosine EIA Kit - 2008-05-21 619.932353985792 8-hydroxy-2-deoxy-guanosine-eia-kit 8-OH-dG ELISA Kit; DNA Damage EIA Kit solid plates oxidative injury stress aging cancers diabetes hypertension hydroxyl radicals peroxynitrite plasmas cells lysates tissues urine creatinine LC-MS liquid DNA damage kits EIAs chormatography mass spectrometry kits enzyme immunoassays elisas 8-OH-2-d 8OH2d 8 oxo deoxyguanine deoxyguanosine hydroxy ohdg 2 EIA/ELISA assays 619.932353985792
589451 AcSDKP EIA Kit - 102.998563535911 acsdkp-eia-kit N-Acetyl Ser-Asp-Lys-Pro EIA Kit; AcSDKP ELISA Kit N-Acetyl-Seryl-Aspartyl-Lysyl-Proline serine aspartamine lysine measures kits eias enzyme immunoassays ELISAs growth regulatory hormones plasma urine spi-bio spibio A05881 atherosclerosis hypertension endocrinology assays 102.998563535911
13620 AL 6598 Exclusive 170291-06-2 97% ✓ 2010-09-16 48.491027624309 al-6598 intraocular pressures IOPs glaucoma PGD2 agonists DP receptors eyes hypertension F2 alpha Prostaglandin Prostaglandin F2 alpha F2alpha Prostaglandin Prostaglandin F2alpha 9alpha,11beta-PGF2 9alpha,11beta PGF2 Prostaglandin F2 Enzaprost F alpha, PGF2 PGF2 alpha PGF2alpha Dinoprost Estrofan PGF2 48.491027624309
10004377 Aldosterone EIA Kit - Monoclonal - 2004-04-21 289.932449355433 aldosterone-eia-kit-monoclonal Aldosterone ELISA Kit - Monoclonal solid plates 582041 steroids hormones mineralocorticoids salt reabsorption electrolytes renin-angiotensin system RAS enzyme immunoassays eias elisas measures kits hypertension endocrinology assays 289.932449355433
13648 Alfuzosin (hydrochloride) 81403-68-1 ≥98% 2010-07-19 0.603038674033 alfuzosin-hydrochloride Uroxatral; SL 77499-10 α1-adrenergic receptors antagonists lower urinary tract symptoms benign prostatic hyperplasia BPH adrenoceptors α1A α1B α1D contractions smooth muscles antihypertensives vasodilators urinary flow 133880-44-1 Urion Alfoten SL 77-499-10 anti-hypertensives alpha 1 .alpha.1 Xatral Quinazolines 0.603038674033
10010663 Amlodipine-d4 (besylate) - ≥99% deuterated product 2009-08-10 0E-12 amlodipine-d4-besylate deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry dihydropyridine pyridines calcium channel blocker angina pectoris hypertension 88150-42-9 0E-12
589301 Angiotensin II EIA Kit - 155.747090176983 angiotensin-ii-eia-kit Angiotensin II ELISA Kit hypertension angiotensin measures kits eias enzyme immunoassays ELISAs spi-bio spibio A05880 atherosclerosis endocrinology assays 155.747090176983
13523 Apelin-13 217082-58-1 ≥95% 2010-06-29 51.080481452249 apelin-13 ligands APJ receptors central nervous system cardiovascular functions fluid homeostasis neurosciences hypertension diabetes metabolic syndrome insulin HIV aids Peptide Factors Paracrine Paracrine Protein Factors Paracrine Peptide Factors Growth Factors 51.080481452249
13524 Apelin-36 252642-12-9 ≥95% 2011-04-04 55.485883977900 apelin-36 agonists receptors APJ cardiovascular functions fluids homeostasis hypertension insulin sensitivity apelin-17 apelins 17 13 36 apelin-13 HIV infections peptides mature G protein-coupled GPCR c-protein coupled 55.485883977900
583951 Arginine Vasopressin EIA Kit - 2007-07-19 138.780530867163 arginine-vasopressin-eia-kit Vasopressin EIA Kit; AVP ELISA Kit; Antidiuretic Hormone (ADH) EIA Kit; Argipressin EIA Kit solid plates enzymes immunoassays measurements arg8 measures kits eias ELISAs AChE acetylcholinesterases plasmas serums argipressin antidiuretic hormones ADH amino acids peptides regulates regulation renal water excretion cardiovascular mammals epithelial cells urinary tracts urine blood stimulates stimulation constriction capillaries aterioles pressure depressions congestive hearts failures anxious-retarded argipressins APH antidiuretics endocrinology assays 10009345 138.780530867163
589401 Atriopeptin (rat) EIA Kit - 37.020331491713 atriopeptin-rat-eia-kit Atriopeptin (rat) ELISA Kit naturiuretic auriculin measures kits eias enzyme immunoassays ELISAs atherosclerosis pi-bio spibio A05103 hypertension endocrinology assays 37.020331491713
10007927 AUDA Exclusive 479413-70-2 >98% ✓ 2006-04-28 21.561994423982 auda epoxides hydrolases hypertension dihydroxy-eicosatrienoic acids DHETs 11(12)-EETs 14(15)-EETs blood pressure soluble sEH inhibits inhibitors inhibition peroxisome proliferator-activated receptors PPARalpha PPAR.alpha. DiHETrEs EpETrEs endocrinology 21.561994423982
10489 Candesartan cilexetil 145040-37-5 ≥98% 2011-04-08 7.204143646409 candesartan-cilexetil TCV-116 angiotensin II receptors antagonists hypertension diabetes AT1 type 1 stress diastolic blood pressure anti-hypertensive antihypertensive 7.204143646409
10005186 CAY10441 Exclusive 221529-58-4 >98% ✓ 2004-09-16 119.233397790055 cay10441 RO1138452 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma cyclic AMP cAMP adenylate cyclase 4,5-dihydro-1H-imidazol-2-yl-4-4-isopropoxy benzyl phenylamine atherosclerosis 119.233397790055
10005913 CAY10449 Exclusive - >98% ✓ 2004-10-26 93.114659300184 cay10449 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma adenylate cyclase cyclic AMP cAMP iloprost athersclerosis CAY 10449 93.114659300184
10012447 CG 4305 - ≥95% 2010-05-12 50.951981057616 cg-4305 antithrombotic PGI2 epoprostenol prostacyclins platelets aggregation 89955-40-8 PGs prostaglandins I2 cartoid artery thrombosis inhibits inhibited inhibition inhibitory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)Isomer Epoprostenol Sodium Prostaglandin I(2) Prostaglandin I2 Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX 50.951981057616
30001 cGMP Alprostadil GMP API 745-65-3 0E-12 cgmp-alprostadil Prostaglandin E1 0E-12
30024 cGMP Alprostadil-Alfadex GMP API 93591-00-5 2009-06-26 0E-12 cgmp-alprostadil-alfadex Prostaglandin E1 with α-cyclodextrin 0E-12
30010 cGMP Epoprostenol (sodium salt) GMP API 61849-14-7 2008-04-28 0E-12 cgmp-epoprostenol-sodium-salt Prostaglandin I2 (sodium salt); Prostacyclin (sodium salt) 0E-12
589101 CGRP (human) EIA Kit - 279.802209944751 cgrp-human-eia-kit Calcitonin Gene-Related Peptide (human) EIA Kit; CGRP (human) ELISA Kit calcitonin peptides measures kits eias enzyme immunoassays ELISAs spi-bio neurochemistry neuroscience spibio A05481 endocrinology assays 279.802209944751
10007923 CUDA Exclusive 479413-68-8 ≥98% ✓ 2006-04-28 16.841450276243 cuda epoxides hydrolases hypertension dihydroxy eicosatrienoic acids DiHETrEs DHETs 11(12)-EETs 14(15)-EETs EpETrEs blood pressure soluble sEH inhibits inhibitors inhibition peroxisome proliferator-activated receptors PPARalpha PPAR.alpha. activates activation endocrinology 16.841450276243
10018 DDMS 206052-03-1 >98% 2005-02-22 4.754143646409 ddms Dibromo-dodecenyl-methylsulfimide 20-HETEs inhibits inhibitors inhibition synthesis CYP450-4A2 renal hypotension vascular homeostasis circulation kidneys vasodilation vasodilators NONOates CYP4A2 donors cytochrome 4.754143646409
10006865 Docosahexaenoic Acid methyl ester 2566-90-7 ≥98% 2005-09-06 77.203351749540 docosahexaenoic-acid-methyl-ester Cervonic Acid methyl ester; DHA methyl ester polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 esters diets dietary supplements hypertension neonatal photoreceptor degeneration retinitis pigmentosa depiration neural tissues retina 77.203351749540
10008610 Epoxy Fluor 7 Exclusive 863223-43-2 ≥98% ✓ 2006-08-30 10.751329419889 epoxy-fluor-7 epoxides hydrolases fluorescence enzymes activity inhibition screening hypertension inflammation sepsis EETs DHETs EpETrEs DiHETrEs fluorescent SEH soluble endocrinology 10.751329419889
10010559 HA-1077 (hydrochloride) 203911-27-7 ≥98% 2008-09-03 68.667826887661 ha-1077-hydrochloride Eril; Fasudil; AT-877 protein kinase inhibitors inhibits inhibition ROCK-II ROCKII PRK2 MSK1 MAPKAP-K1b vasodilation hypertension diabetes renal nephropathy cancers 105628-07-7 AT877 AT 877 hydrochloride dihydrochloride monohydrochloride HCl HA1077 HA 1077 68.667826887661
10011038 Hemopressin - 2009-08-13 32.880710339384 hemopressin peptides antagonist inhibitors inhibits inhibition hypertension binding asoactive vasoactive cannabinoids cbs synthetic 32.880710339384
10005518 IP Receptor (human) Polyclonal Antibody - 2004-10-21 24.633523634131 ip-receptor-human-polyclonal-antibody Prostaglandin I2 Receptor; Prostacyclin Receptor; PGI2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors immunoblotting atherosclerosis 24.633523634131
10010572 Lercanidipine-d3 (hydrochloride) - >99% deuterated product 2008-04-14 0E-12 lercanidipine-d3-hydrochloride SPI blocker calcium dihydropyrine neurochemistry 0E-12
16833 Lisinopril 76547-98-3 ≥98% 2009-03-09 2.545248618785 lisinopril MK 522; MK 521 inhibitors inhibits inhibition angiotensin I II ACE endothelin 1 nitric oxide renin hypertension diabetes 2.545248618785
700570 L-Theanine Fluorometric Assay Kit Exclusive - ✓ 2011-05-31 240.716457949662 l-theanine-fluorometric-assay-kit 5-N-ethyl-Glutamine; Glutamic Acid γ-ethyl amide; γ-ethylamino-L-Glutamic Acid; γ-Glutamylethylamide kits assays measures measurements glutamines amino acids aa Camellia sinensis C. sinensis green teas japonica sasanqua mushrooms Xerocomus badius X. badius water-solubles non-proteins plants leaves umami humans immune systems .gamma..delta. gammadelta γδ T cells T-cells infection-fighting infections antigens ethylamine renal metabolites brains .alpha.-waves alpha-waves α-waves alertness schizophrenia neuroprotective effects glutamates receptors N-methyl-D-aspartate NMDA calcium Ca Ca2+ intracellular animals anthracyclines hypertensives rats antihypertensives blood pressures dopamines norepinephrines serotonins 240.716457949662
10010971 Luminex® 11-dehydro Thromboxane B2 Kit - 2008-01-24 89.828657151627 luminex-11-dehydro-thromboxane-b2-kit Luminex® 11-dehydro TXB2 Kit thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays 89.828657151627
10010412 MRE-269 Exclusive 475085-57-5 ≥98% ✓ 2008-11-06 64.629803080342 mre-269 MRE269 prostaglandins PGI2 IP receptors inflammation NS-304 NS304 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs prodrugs 64.629803080342
11106 Nifedipine New 21829-25-4 ≥98% 2011-11-22 12.462962962963 nifedipine Nifediac™; BAY 1040; Procardia™; Nifedical™; Cordipin; Adalat™ dihydropyridine calcium channel blockers Ca2+ hypertension angina endothelia cardiology preterm labor Raynaud’s phenomenon pulmonary edema coronary vasodilator antioxidant gastric acids 11104-22-6 101539-70-2 101554-38-5 adalat nifediac cordipin procardia nifedical adalate adapine adapress alat alfadat alonix angipec anifed BAY-1040 BAY1040 BAY-a BAYa BAY-a 1040 bonacid calcigard calcibloc calciguard calcilat camont cardifen cardionorm chronadalate coral cordafen cordaflex cordilan corinfar corotrend corynphar depin dignokonstant dilafed dilcor duranifin ecodipin fedcor fenamon fedipin fenihidine glopir hadipine hexadilat introcar kordafen macorel megalat myogard nifedilat nifedirex nifelantern nifelat nifensar niphedipine nyefax orix oxcord pidilat procardia sepamit TN 873R TN-873R TN873R tensopin tibricol UV-ENP 349PINa vasdalat vasofed xinran zenusin 12.462962962963
10010653 Nisoldipine-d3 - ≥99% deuterated product 2009-04-15 0E-12 nisoldipine-d3 63675-72-9 86189-67-5 calcium channel dihydropyridine cardiac failure angina deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 0E-12
10010411 NS-304 475086-01-2 >98% 2008-04-09 41.397650158956 ns-304 ACT-293987; Selexipag prostaglandins PGI2 IP receptors inflammation MRE-269 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs 41.397650158956
10006803 O-1602 317321-41-8 >98% 2005-09-12 10.751519337016 o-1602 abnormal cannabidiols CB1 CB2 receptors vasorelaxation neurochemistry neuroscience central cannabinoids peripheral selective antagonists nonendothelium-dependant vasodilation nitric oxides NOs inhibits inhibitors inhibition vasorelaxant cannabinoids cbs synthetic 10.751519337016
10006804 O-1821 35482-50-9 >97% 2005-09-12 18.792081031307 o-1821 abnormal cannabidiol central cannabinoids peripheral CB1 CB2 receptors vasorelaxation neurochemistry neuroscience antagonists synthetic regioisomer endothelium dependent vasodilation cannabinoids cbs synthetic 18.792081031307
10004914 O-1918 536697-79-7 >98% 2005-09-09 9.388121546961 o-1918 antagonists abnormal cannabinoids cannabidiols cannabidiol-mediated synthetic regioisomers CB1 CB2 responsiveness psychotropics activity induces endothelium-dependent vasodilations NO-independent nitric oxides mechanisms analogs endothelial receptors inhibits inhibition inhibitors vasorelexants in vitro blocks induced activations PI3-kinases Akt pathway umbilical vein cells neuroscience neurochemistry O1918 0-1918 cannabinoids cbs synthetic 9.388121546961
600240 Orexin 1 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 0.869820441989 orexin-1-receptor-step-reporter-assay-kit-luminescence OX1R hypercretins 1 orexins 2 A orexin-2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 0.869820441989
600250 Orexin 2 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 1.019337016574 orexin-2-receptor-step-reporter-assay-kit-luminescence OX2R hypercretins 1 orexin 2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 1.019337016574
70515 Ozagrel 82571-53-7 >98% 0.656629834254 ozagrel OKY-046 thromboxanes synthases inhibitors inhibits imidizoles TXAs antihypertensive inhibition atherosclerosis 0.656629834254
10007852 Pargyline (hydrochloride) 306-07-0 >98% 2006-08-30 51.847016574585 pargyline-hydrochloride MAO inhibitors inhibits inhibition ROS-mediated Hypertension 3 blood pressures systolic brains monocytes hypertrophy reactive oxygen species endocrinology 51.847016574585
10009567 PCSK9 Western Ready Control - 2007-01-31 8.248634569850 pcsk9-western-ready-control Proprotein Convertase Subtilisin Kexin 9; NARC-1 PSEC0052 subtilisin serine proteases LDLs low density lipoproteins cholesterol receptors golgi atherosclerosis 8.248634569850
10009134 PHOME Exclusive 1028430-42-3 >98% ✓ 2007-01-16 16.861707182320 phome sEH epoxides hydrolase inhibitors inhibition inhibits substrates HTS fluorogenic high throughput screening fluorescent fluorescence hypertension endocrinology 16.861707182320
10011724 Propenyl-L-NIO (hydrochloride) Exclusive - >90% ✓ 2008-08-19 5.421243093922 propenyl-l-nio-hydrochloride ENIPO nitric oxide synthase NOS iNOS selective inhibitors inhibits inhibition 5.421243093922
10007599 Prorenin (human recombinant) - ≥99% by SDS-PAGE 2005-10-19 100.280386740331 prorenin-human-recombinant enzymes aspartyl proteases angiotensins II glycoproteins angiotensinogen salt balance hypertension angiotensinogens kidney renal preprorenin endocrinology 100.280386740331
10010 Prostaglandin A1 14152-28-4 >98% 139.226084254143 prostaglandin-a1 PGA1 prostaglandins renal vasodilation pge1 dehydration semen antimitotic antiproliferative 139.226084254143
10020 Prostaglandin A1 ethyl ester 93464-24-5 >98% 68.835801104972 prostaglandin-a1-ethyl-ester PGA1 ethyl ester PGA1 renal vasodilation prostaglandins esters prodrugs lipid-soluble 68.835801104972
9000184 Prostaglandin A1 methyl ester Exclusive 26771-94-8 ≥98% ✓ 2010-11-08 18.494516574585 prostaglandin-a1-methyl-ester PGA1 methyl ester hypertension cancers lipophilic analogs PGA1 prostaglandins 18.494516574585
12990 Prostaglandin D3 Exclusive 71902-47-1 >98% ✓ 74.783775322283 prostaglandin-d3 PGD3 PGD3 omega-3 w-3 .omega.-3 metabolites EPA eicoaspentaenoic acid prostaglandins 74.783775322283
13010 Prostaglandin E1 745-65-3 >98% 56.894554941681 prostaglandin-e1 Alprostadil; PGE1 PGE1 vasodilation atherosclerosis erectile dysfunction prostaglandins pharma:1 56.894554941681
13010.1 Prostaglandin E1 Analytical Reference Standard 745-65-3 >99% 31.944162062615 prostaglandin-e1-analytical-reference-standard Alprostadil; PGE1 PGE1 vasodilation USP erectile dysfunction prostaglandins 31.944162062615
10006906 Renin Fluorogenic Substrate - >95% 2006-12-12 70.916556169429 renin-fluorogenic-substrate substrates aspartyl proteases angiotensinogens peptides peptide-EDANS non-fluorescent quenching molecules Dabcyl fluorescent excitation emission hypertension endocrinology 70.916556169429
10006217 Renin (human recombinant) - >99% by SDS-PAGE 2004-12-13 86.178273480663 renin-human-recombinant enzymes aspartyl proteases angiotensins II glycoproteins angiotensinogen salt balance hypertension angiotensinogens kidney renal preprorenin atherosclerosis endocrinology 86.178273480663
10006270 Renin Inhibitor Screening Assay Kit - 2005-05-04 71.973945160630 renin-inhibitor-screening-assay-kit Protease measurement assays aspartyl renal juxtaglomerular cells sodium depletion blood volume pressure .beta.-adrenergic stimulation angiotensinogens angiotensins I II converting ACE monomeric zinc metalloenzymes vascular endothelium messengers RAS vasoconstrictor peripheral hypertension receptors blockers fluorescence fluorescent fluorometric atherosclerosis endocrinology 71.973945160630
13082 Resorcinolnaphthalein 41307-63-5 ≥98% 2009-02-24 63.218314917127 resorcinolnaphthalein NSC 354317 angiotensin converting enzyme 2 ACE2 hypertension blood pressure activators fibrosis 63.218314917127
10010662 Rilmenidine-d4 85047-14-9 ≥99% deuterated product 2009-04-17 0.440193370165 rilmenidine-d4 adrenergic agonist agents antihypertensive deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 0.440193370165
10008609 S-NEPC Exclusive - >98% ✓ 2007-05-01 11.260165745856 s-nepc Cytochrome P450 CYP450 subtrates glutathione s-transferase hydrolases procine liver carboxylesterase hydrolysis spectrophotometry (+)-NEPC (-)-NEPC hypertension sEH epoxides sEH inhibitor substrate GST endocrinology 11.260165745856
600090 Soluble Epoxide Hydrolase Cell-Based Assay Kit - 2009-05-14 13.906172059984 soluble-epoxide-hydrolase-cell-based-assay-kit sEH Cell-Based Assay Kit kits assays measuring measurement mammalian epoxides α/β-hydrolases enzymes catalyzes hydrolysis exogenous endogenous vicinal diols homodimers C-terminal N-terminal domains vasodilatory vasodilation anti-inflammatory hypertension vascular inflammation inhibitors therapeutics fluorescence-based fluorescent whole cells Epoxy Fluor 7 6-methoxy-2-naphthaldehyde AUDA 13.906172059984
10011669 Soluble Epoxide Hydrolase (human recombinant) - ≥95% 2008-07-02 23.122430939226 soluble-epoxide-hydrolase-human-recombinant CEH; Cytosolic Epoxide Hydrolase; sEH; Epoxide Hydrolase 2; EPHX2 recombinant proteins mammalian hydrolases enzymes exogenous endogenous his-tags hexahistindes His-tagged anti-inflammatory inflammation sehs hydrolases hydrolysis 23.122430939226
10011671 Soluble Epoxide Hydrolase Inhibitor Screening Assay Kit - 2009-02-24 22.916324432167 soluble-epoxide-hydrolase-inhibitor-screening-assay-kit sEH Inhibitor Screening Assay Kit epoxides hydrolases sEHs inhibits inhibition assays kits fluorescence-based catalyzes hydrolysis exogenous endogenous vicinal diols substrates EETs epoxyeicosatrienoic acids vasodilatory vasodilation anti-inflammatory molecules therapy therapeutics hypertension vascular diseases PHOME (3-phenyl-oxiranyl)-acetic acid cyano-(6-methoxy-naphthalen-2-yl)-methyl ester 6-methoxy-2-naphthaldehyde excitation emission wavelengths a/b-hydrolases alpha/beta-hydrolases .alpha./.beta.-hydrolases enzymes homodimers C-terminal C-terminus animals models cyanohydrins cyanide ions 22.916324432167
10011670 Soluble Epoxide Hydrolase (mouse recombinant) Exclusive - ≥95% ✓ 2008-07-01 5.371944751380 soluble-epoxide-hydrolase-mouse-recombinant sEH; Epoxide Hydrolase 2; EPHX2; Cytosolic Epoxide Hydrolase; CEH recombinant proteins mammalian hydrolases enzymes exogenous endogenous hexahistidine His-tag His-tagged N-terminal anti-inflammatory inflammation 10278 5.371944751380
10010146 Soluble Epoxide Hydrolase Polyclonal Antibody - 2008-03-03 7.101390965226 soluble-epoxide-hydrolase-polyclonal-antibody Epoxide Hydrolase 2; EPHX2; sEH; Cytosolic Epoxide Hydrolase (CEH) metabolism hypertension inflammation EpETrEs EETs DiHETrEs DHET inhibitors inhibit inhibitions epoxyeicosatrienoic acids eicosatrienoic WB western blots blotting immunoblotting 7.101390965226
11120 TPPU Exclusive New 1222780-33-7 ≥98% ✓ 2011-10-26 6.444971864129 tppu soluble epoxide hydrolase sEH inflammation hypertension cardiovascular disease neuroscience inhibitors inhibits inhibition pharmacokinetics 6.444971864129
10162 Treprostinil 81846-19-7 >98% 2005-08-30 218.580605605111 treprostinil Remodulin® primary pulmonary hypertension PPH arterial vascular resistance stable analogs prostacyclins increase plasma half-life vasodilatory inhibits inflammatory cytokines inhibition inhibitors GM-CF human alveolar macrophages NF-KB NF-.kappa. translocations nucleus NF-kappaB nfkb nf-kb NF-.kappa.B atherosclerosis Tyvasos Tyvaso® 218.580605605111
700320 Uric Acid Assay Kit - 2010-08-30 118.175530072317 uric-acid-assay-kit Urate Assay Kit kits assays measures measurement acids human purines metabolisms urine serum renal excretion excreted allantoin enzymes urate oxidases uricase genes obesity alcohol consumption hyperuricemia gout kidney stones metabolic syndromes hypertension cardiovascular diseases exercise-induced acute failure hypouricemia 118.175530072317
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?